Hereditary ataxia is a group of genetic disorders that damage the brain’s ability to coordinate movement. The word “ataxia” means lack of coordination, and in these conditions, faulty genes cause progressive deterioration of the cerebellum, the part of the brain responsible for precise, well-timed movement. Globally, hereditary ataxias affect roughly 6 in every 100,000 people, with autosomal dominant forms accounting for about 2.7 per 100,000 and autosomal recessive forms about 3.3 per 100,000.
What Happens in the Brain
The cerebellum sits at the back of the brain and acts as a movement control center. Its job is to make sure your muscles fire in the right order, at the right time, with the right amount of force. The key players inside the cerebellum are specialized nerve cells called Purkinje neurons. These cells are the central processing units of the cerebellar system: they receive incoming sensory and motor signals, integrate that information, and send the final output to deeper brain structures that execute smooth, coordinated movement.
Purkinje neurons are unusual in that they fire rapid, rhythmic electrical signals on their own, a property sometimes called “pacemaking.” This steady firing pattern is essential for the cerebellum to regulate movement properly. In hereditary ataxia, genetic mutations disrupt these neurons in various ways. Some mutations cause Purkinje cells to accumulate toxic protein clumps. Others alter the ion channels in the cell membrane that maintain the pacemaking rhythm. Still others simply cause Purkinje neurons to die off over time. When these cells malfunction or disappear, the cerebellum can no longer fine-tune movement, and coordination progressively breaks down.
The Two Main Inheritance Patterns
Autosomal Dominant (Spinocerebellar Ataxias)
In autosomal dominant hereditary ataxia, inheriting just one copy of the faulty gene from one parent is enough to cause the disease. These are collectively called spinocerebellar ataxias, or SCAs, and there are over 40 identified types. Five of them (SCA1, SCA2, SCA3, SCA6, and SCA7) account for about 60% of all identified cases in the United States. SCA3, also known as Machado-Joseph disease, is the most common worldwide.
Most of these common SCAs share a similar genetic mechanism: a section of DNA containing a short repeating sequence (CAG) gets abnormally expanded. The longer the expansion, the more toxic the resulting protein tends to be, and generally the earlier symptoms begin. Certain populations carry much higher rates due to founder effects. In Portugal’s Azores islands, for example, SCA3 prevalence reaches 43 per 100,000, and on Flores Island specifically, it climbs to an extraordinary 971 per 100,000.
Autosomal Recessive (Including Friedreich’s Ataxia)
Autosomal recessive ataxias require two copies of the defective gene, one from each parent. People who carry only one copy are unaffected carriers. The most common form in this category is Friedreich’s ataxia, which is also the most common hereditary ataxia overall, affecting roughly 1 in 50,000 people in the United States. It’s caused by a mutation in the FXN gene, which provides instructions for making a protein called frataxin. In Friedreich’s ataxia, an abnormal DNA repeat (GAA) appears hundreds of times where it shouldn’t, drastically reducing frataxin production.
What makes Friedreich’s ataxia distinctive is that it affects far more than coordination. It commonly causes heart disease (cardiomyopathy), scoliosis, high-arched feet, diabetes, hearing loss, vision loss, and fatigue. The heart involvement is particularly significant because cardiomyopathy is the leading cause of death in Friedreich’s ataxia patients.
Symptoms and How They Progress
The hallmark symptoms of hereditary ataxia center on the cerebellum’s role in movement. The most common initial complaint is difficulty walking, often described as a wide-based, staggering gait. Over time, people typically develop:
- Trunk instability: difficulty sitting upright without support
- Limb incoordination: trouble reaching accurately for objects, with overshooting or undershooting the target
- Speech changes: slurred, slowed, or scanning speech with variable pitch and volume
- Eye movement problems: involuntary eye movements (nystagmus), difficulty tracking objects smoothly
- Slowed alternating movements: difficulty with rapid hand movements like flipping the palm up and down
Age of onset varies dramatically by type. Friedreich’s ataxia typically appears before age 20. Ataxia-telangiectasia begins before age five. SCA6, on the other hand, often doesn’t appear until after age 50. Some types, like SCA2 and SCA7, can even present in infancy. Each type also tends to carry its own signature features beyond the core coordination problems. SCA7 patients almost invariably develop vision loss from macular degeneration. SCA3 commonly causes severe dizziness and muscle cramping. Friedreich’s ataxia is marked by absent knee and ankle reflexes combined with scoliosis and heart disease.
How It’s Diagnosed
Diagnosing hereditary ataxia involves piecing together several types of information. Doctors start with a detailed medical history, paying close attention to age of onset, family history, and which symptoms appeared first. These details can narrow down the possibilities considerably. Brain imaging with MRI typically reveals cerebellar shrinkage or underdevelopment, confirming that the cerebellum is structurally affected.
The definitive step is genetic testing. For the most common types, this means looking for abnormally expanded DNA repeats and measuring exactly how long they are, since the size of the expansion often correlates with disease severity and onset age. Genetic panels can now test for multiple ataxia types simultaneously. In cases where the common repeat expansions come back negative, broader genomic sequencing may identify rarer mutations. Establishing the exact genetic cause matters not just for the individual but for family members who may want to know their carrier status or risk.
Life Expectancy and Disability
Prognosis depends heavily on which type of hereditary ataxia a person has. A large study of dominant ataxias found that patients with the common polyglutamine-expansion SCAs (types 1, 2, 3, 6, and 7) had a median survival of 68 years, compared to 80 years for patients with other, rarer SCA mutations. Among the polyglutamine types, SCA1 carries the worst prognosis, with a median age at death of 63 years.
Disability accumulates at different rates as well. By age 60, about 30% of polyglutamine SCA patients used a wheelchair, compared to just 3% of those with other SCA types. SCA7 tends to progress fastest in terms of mobility loss, while SCA6 generally progresses more slowly. After roughly 9 years of disease, about half of polyglutamine SCA patients needed assistance walking.
Friedreich’s ataxia, because of its cardiac involvement, carries its own distinct survival profile. Heart failure and heart rhythm problems are the primary life-limiting complications, making cardiac monitoring a critical part of ongoing care.
Treatment and Rehabilitation
For most hereditary ataxias, there is no cure and no medication that stops the underlying nerve degeneration. However, one important exception arrived in 2023 when the FDA approved Skyclarys (omaveloxolone) as the first treatment specifically for Friedreich’s ataxia. It’s taken as a daily oral capsule. Gene therapy trials are also underway, including a Phase 1/2 study targeting the heart disease component of Friedreich’s ataxia, though these remain in early stages.
The cornerstone of management for all hereditary ataxias is rehabilitation, and the evidence strongly supports starting early. Physical therapy should begin as soon as a diagnosis is made, even when symptoms are mild. Intensive coordination and balance training has been shown to meaningfully improve motor performance and reduce ataxia symptoms. Programs typically include exercises like single-leg standing for static balance, sidestep drills for dynamic balance, and fall-prevention strategies.
Speech and swallowing therapy is equally important to begin early. Many hereditary ataxias eventually affect the muscles used for speaking and swallowing, and early intervention can preserve communication ability and reduce the risk of choking or aspiration. Occupational therapy helps people adapt daily activities to their changing abilities, and combining intensive physical and occupational therapy appears to be more effective than either one alone. Rehabilitation should continue throughout all stages of the disease, adapting as needs change, because even in advanced stages it can improve quality of life and functional independence.
Hereditary vs. Acquired Ataxia
Not all ataxia is inherited. Ataxia can also result from alcohol damage, vitamin deficiencies, autoimmune conditions, or other causes. A few features help distinguish hereditary forms from acquired ones. Hereditary ataxias typically begin gradually, progress slowly over years, and often involve a family history of similar symptoms. Acquired ataxias may appear more suddenly or have a clear external trigger.
Specific clinical patterns also point toward genetic causes. The combination of absent reflexes, scoliosis, high-arched feet, and heart disease strongly suggests Friedreich’s ataxia. Vision loss from macular degeneration points to SCA7. Immune problems or increased cancer risk in a young child suggest ataxia-telangiectasia. Alcohol-related cerebellar damage, by contrast, predominantly affects trunk stability and gait while leaving arm coordination relatively intact. Vitamin B12 deficiency produces a distinctive high-stepping gait with sensory loss and exaggerated reflexes, a pattern that looks quite different from most genetic ataxias.